scholarly journals Effects of 8-hour time restricted feeding on body weight and metabolic disease risk factors in obese adults: A pilot study

2018 ◽  
Vol 4 (4) ◽  
pp. 345-353 ◽  
Author(s):  
Kelsey Gabel ◽  
Kristin K. Hoddy ◽  
Nicole Haggerty ◽  
Jeehee Song ◽  
Cynthia M. Kroeger ◽  
...  
2020 ◽  
Vol 4 (Supplement_2) ◽  
pp. 584-584
Author(s):  
Sofia Cienfuegos ◽  
Kelsey Gabel ◽  
Faiza Kalam ◽  
Mark Ezpeleta ◽  
Vasiliki Pavlou ◽  
...  

Abstract Objectives This study was undertaken to compare the effects of 4-h TRF to that of 6-h TRF on body weight, body composition, and metabolic disease risk factors in adults with obesity. We hypothesized that 4-h TRF would produce the greatest decreases in body weight, fat mass, blood pressure, and insulin resistance, compared to 6-h TRF. Methods Adults with obesity (n = 49) were randomized to 1 of 3 interventions for 8 weeks: 4-h TRF (ad libitum eating between 3:00 to 7:00 pm, water fasting between 7:00 to 3:00 pm); 6-h TRF (ad libitum eating between 1:00 to 7:00 pm, water fasting between 7:00 to 1:00 pm); or control (ad libitum food intake with no timing restrictions). Results Body weight decreased similarly in the 4-h TRF group (–3.3 ± 0.5%) and 6-h TRF group (–2.6 ± 0.5%) relative to controls over 8 weeks (P < 0.001). Fat mass, blood pressure and insulin sensitivity also decreased in the 4-h TRF and 6-h TRF groups versus controls. LDL cholesterol, HDL cholesterol, triglycerides, fasting glucose, and HbA1c were not significantly different from controls after 8 weeks. Conclusions This is the first trial to examine the effects of 4-h vs. 6-h TRF on body weight and metabolic disease risk factors. We show here that 8 weeks of 4-h and 6-h TRF decreases body weight by ∼3–4% relative to controls. We also demonstrate that this fasting regimen produces significant reductions in blood pressure, fat mass, insulin and insulin resistance. These preliminary data offer promise for the use of 4-h and 6-h TRF as a weight loss techniques in adults with obesity, but larger, longer-term trials are needed to confirm these findings. Funding Sources Department of Kinesiology and Nutrition, University of Illinois Chicago


2019 ◽  
Vol 15 (1) ◽  
Author(s):  
Shiva Raj Mishra ◽  
Saruna Ghimire ◽  
Chandni Joshi ◽  
Bishal Gyawali ◽  
Archana Shrestha ◽  
...  

2021 ◽  
Vol 5 (Supplement_2) ◽  
pp. 366-366
Author(s):  
Martin Jr Rosas ◽  
Sherry Pinneo ◽  
Celeste O'Mealy ◽  
Changqi Liu ◽  
Mark Kern ◽  
...  

Abstract Objectives Mangos contain many beneficial dietary compounds including vitamins, minerals, fiber, and are a unique source of certain polyphenols such as mangiferin. Accumulating evidence from in vitro and animal studies have demonstrated that mangos may have antidiabetic, anti-inflammatory, and cardioprotective properties. However, the effects of fresh mango consumption in humans are less clear. The objective of this study was to examine the effects of fresh mango consumption compared to an isocaloric snack (low-fat cookies) on body weight, body fat, blood pressure, glucose, insulin, lipid profiles, liver function enzymes, inflammation, and antioxidant activity in overweight and obese adults. Methods In a randomized crossover design, 27 overweight and obese adults (11 females, 16 males, age 26 ± 8.1 years) consumed 100 Kcal of fresh mangos (166g) or isocaloric low-fat cookies (24g) daily for 12 weeks. Following an overnight fast, a venous blood draw was taken at baseline, week 4, and week 12. Blood samples were analyzed for glucose, insulin, lipid profiles, liver function enzymes, C-reactive protein (CRP), and total antioxidant capacity (TAC). At each visit, body weight, body fat percentage, and blood pressure were measured. Results Twelve weeks of daily mango consumption significantly decreased blood glucose, CRP, and aspartate transaminase (AST) activity while TAC significantly increased (P < 0.05). There were no significant changes in body weight, body fat percentage, blood pressure, insulin, lipid profile, or other liver function enzymes following mango consumption. Cookie consumption significantly increased insulin, CRP, and triglycerides (P < 0.05). Conclusions Mango consumption improved certain chronic disease risk factors including reductions in fasting glucose and inflammation while lipid profiles and anthropometric measurements were not affected. These results suggest that relative to the control snack, daily mango consumption may improve certain risk factors associated with overweight and obesity and should be considered for future research as they contain unique bioactive compounds. Funding Sources This study was funded by the National Mango Board.


2018 ◽  
Vol 36 ◽  
pp. e339
Author(s):  
Shiva raj Mishra ◽  
Dinesh Neupane ◽  
Saruna Ghimire ◽  
Chandni Joshi ◽  
Yashashwi Pokharel ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document